Autres langues ContraFect Corporation

Actions

CFRXQ

US2123264093

Marché Fermé - OTC Markets Autres places de cotation 15:46:34 25/04/2024			Varia. 5j.	Varia. 1 janv.
0,018 ^USD	0,00 %		-14,29 %	-40,00 %

2023	ContraFect Corporation annonce la démission de ses dirigeants	CI
2023	ContraFect Corporation annonce la démission de Michael Messinger en tant que directeur général	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

North American Morning Briefing : Stock Futures -2-	19/04
North American Morning Briefing : Big Banks Kick -2-	12/04
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	05/04
Bidding Procedure Approved for ContraFect Corporation	09/02
Motion for Asset Sale Filed by ContraFect Corporation	12/01
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Financial Officer	05/12
ContraFect Corporation Announces Management Resignations	05/12
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Executive Officer	05/12
ContraFect Corporation Filed for Bankruptcy	04/12
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	20/11
ContraFect Corporation Announces Chief Executive Officer Changes	15/11
ContraFect Corporation Announces Executive Changes	15/11
ContraFect Corporation Appoints Michael Messinger as Chief Financial Officer	15/11
ContraFect Corporation Implements Restructuring Plan Resulting in Reduction to Workforce from A Total of 23 Employees to Five Employee	15/11
ContraFect: Q3 Earnings Snapshot	14/11
ContraFect Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	13/11
ContraFect Corporation(OTCPK:CFRX) dropped from S&P TMI Index	13/11
ContraFect Corporation(OTCPK:CFRX) dropped from NASDAQ Composite Index	08/11
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study	16/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ContraFect Corporation

Actions

CFRXQ

US2123264093

Autres langues

Filtres